![Biomedicina - Home page [accesskey X]](../images/aa_logo.gif)
BITA
Patents
| CODE | DESCRIPTION | PRIORITY | LICENSE |
|---|---|---|---|
| 98002 | Interferon alfa 5 use as antiviral for hepatitis C treatment | Sol. ES9801003; 13/05/1998 |
DIGNA BIOTECH |
| 98003 | Peptide inhibitors of TGF beta 1 | Sol. ES9802465; 24/11/1998 |
DIGNA BIOTECH |
| 01008 | Use of Cardiotrophine (CT-1) for the treatment of human liver diseases | Sol. ES200102120; 21/09/2001 |
DIGNA BIOTECH |
| 02007 | Peptides Inhibitors of TGF-beta 1 (II) | Sol. ES200302020; 22/08/2003 | DIGNA BIOTECH |
| 03004 | Hybrid virus (Adenovirus-alfa/ Semliky Forest) to administer and express therapeutics genes in tumour cells | Sol. ES200401219; 20/05/2004 |
DIGNA BIOTECH |
| 04011 | Oxidised Apo A1 as early markers of Hepatocellular carcinoma | Sol. ES200402989; 16/12/2004 |
DIGNA BIOTECH |
| 05003 | Vascular/Lymphatic Endothelial Cells derived from mature adult stem cell | Sol.US 60/652,015; 10/02/2005 | Joint owner with University of Minnesota (USA) |
| 04016 | 5'-metiltioadenosina (MTA) in the prevention and treatment of autoimmune diseases | PCT/ES 2005/000139; 17/03/2005 | DIGNA BIOTECH |
| 05008 | Use of cardiotrophine-1 (CT-1) and alfa interferon (IFNa) for combined treatment in viral diseases | Sol. ES200501468; 16/06/2005 |
DIGNA BIOTECH |
| 04018 | Use of EDA as immune-modulator agent | Sol. ES200501412; 13/06/2005 | DIGNA BIOTECH |
| 05009 | Immune-stimulatory combination for hepatitis C prevention | Sol. ES200601563; 09/06/2006 |
DIGNA BIOTECH |
| 05030 | Use of peptides inhibitor of TGF-beta1 as a immune response modulator | PCT/ES 2005/000569; 24/10/2005 | DIGNA BIOTECH |
| 05029 | New synthetic peptides as T helper (DTh) determinant for universal DR | Sol. ES200503169; 23/12/2005 |
DIGNA BIOTECH |
| 06016 | IL-10 inhibitors peptides (iIL-10) | Sol. ES200700806; 27/03/2007 | DIGNA BIOTECH |
| 06022 | Viral vector as producer for stable cell line generation | Sol. ES200700882; 03/04/2007 |
3P BIOPHARMACEUTICALS |
| 06024 | Escurfine inhibitors peptides (i Fox p3) | Sol. ES200703052; 19/11/2007; PCT / ES2008000716 | DIGNA BIOTECH |
| 06031 | Metalloproteinase 10 as adjuvant for trombolitic treatment (MMP10) | Sol. ES200700501; 26/02/2007 |
DIGNA BIOTECH |
| 07014 | Metalloproteinase 10 Inhibitors as anti-fibrinolitic treatment (iMMP10) | Sol. ES200701786; 26/06/2007 |
DIGNA BIOTECH |
| 07005 | Association of alfa interferon to 4-1BB agonist antibodies for antitumoral treatment (alfa INF+4-1BB agonist) | Sol. ES200702961; 07/11/2007; Sol. PCT/ES2008000693 | DIGNA BIOTECH |
| 06002 | Porphobilinogen deaminase gene therapy | Sol. US 61/100881; 29/09/2008 |
AMT |
| 08023 | Methods and compositions for the treatment of cirrhosis and liver fibrosis | Sol. ES200900846; 27/03/2009 |
DIGNA BIOTECH, sublicensed AMT |
| 07024 | Synergy of silencing post-transcriptional genes combining mRNAi and snRNP (mRNAi + sn RNP U1) | Sol. ES200800222; 29/01/2008 |
DIGNA BIOTECH |
| 07031 | Novel uses for 4-phenylbutyrate (4PBA) and its pharmaceutically acceptable salts | Sol. ES200800736; 13/3/2008 |
DIGNA BIOTECH |
| 07037 | Synergystic combinations of 5'-methylthioadenosine | Sol. ES200800806; 19/03/2008 |
DIGNA BIOTECH |
| 07039 | Viral vectors and methods useful in the preparation of GDNF | Sol. ES200931071; 26/11/2009 |
|
| 08002 | Self-inactivating helper adnoviruses for the production of high-capacity recombinant adenoviruses | Sol. ES200801434; 16/05/2008 |
|
| 07038 | System for packaging of high-capacity adenovirus | Sol. ES200801682; 04/06/2008 |
DIGNA BIOTECH |
| 08005 | Conjugates for the administration of biologically active compounds | Sol. ES200801796; 13/06/2008 |
DIGNA BIOTECH |
| 07017 | Anti-angiogenic agents | Sol. ES200802023; 02/07/2008 | DIGNA BIOTECH |
| 08014 | Novel biomarker as a therapeutic target in lung cancer | Sol. ES200802503; 28/08/2008 |
DIGNA BIOTECH |
| 08007 | Use of phenol soluble modulins for the development of vaccines | Sol. ES200803441; 03/12/2008 |
DIGNA BIOTECH |
| 07022 | Biomarkers for the diagnosis of fibrosis | Sol. ES200900056; 09/01/2009 | DIGNA BIOTECH |
| 07009 | Use of cardiotrophin 1 for the treatment of metabolic diseases | Sol. ES200900396; 12/02/2009 |
DIGNA BIOTECH |
| 08018 | Oncostatin M as an enhancer of the immunostimulatory activity of human epithelial cells | Sol. ES200802835; 07/10/2008 |
DIGNA BIOTECH |
| 08004 | Compounds for the treatment of auricular fibrillation | Sol. ES200502545; 14/10/2005 |
DIGNA BIOTECH |
| 08022 | Neuroprotective properties of 5’-methylthioadenosine | Sol. ES200930298; 11/06/2009 |
DIGNA BIOTECH |
| 06033 | An adapter molecule for the delivery of adenovirus vectors | Sol. PCT/EP2009056053 19/05/2009 |
DIGNA BIOTECH |
| 08025 | Therapeutic compositions for the treatment of diseases caused by HPV | Sol. ES200901847; 11/09/2009 |
DIGNA BIOTECH |
| 08020 | Compositions designed for the inhibition and/or blocking of the epithelial/mesenchymal transition | Sol. ES200930952; 05/11/2009 |
DIGNA BIOTECH |
| 09017 | Regulated expression system | Sol. ES200902122; 05/11/2009 |
|
| 09022 | New conjugates and compositions for immunotheraphy and anti-tumoral treatment | Sol. ES200931158; 11/12/2009 Sol. ES201030813; 27/05/2010 |
|
| 09026 | Compositions for the treatment of infectious and tumoural diseases | Sol. ES201030170; 09/02/2010 |
DIGNA BIOTECH |
| 09028 | New compositions based in the fibronectin extracellular domain a for the treatment of melanoma | Sol. EP10382036.1; 16/02/2010 |
|
| 07013 | Cold organ preservation composition | Sol. ES201030782; 24/05/2010 |
DIGNA BIOTECH |
| 09024 | New compositions and cell therapy for treatment of cirrhosis | Sol. EP10382167.4; 08/06/2010 |
|
| 10001 | Alphaviral vectors and uses thereof for the expression of heterologous genes | Sol. ES201030998; 28/06/2010 |
|
| 08019 | Method for electrochemical detection for sequences of nucleic acids | Sol. ES200701446; 23/05/2007 |
DIGNA BIOTECH |
© Proyecto de Biomedicina CIMA S.L.